These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 38138961)
1. Evaluation of Chelator-to-Antibody Ratio on Development of Tsai SC; Farn SS; Lo WL; Ou Yang FY; Kang YC; Chen LC; Chen KT; Liao JW; Kung JY; Chen JT; Huang FJ Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38138961 [No Abstract] [Full Text] [Related]
2. Immuno-PET Imaging of the Programmed Cell Death-1 Ligand (PD-L1) Using a Zirconium-89 Labeled Therapeutic Antibody, Avelumab. Jagoda EM; Vasalatiy O; Basuli F; Opina ACL; Williams MR; Wong K; Lane KC; Adler S; Ton AT; Szajek LP; Xu B; Butcher D; Edmondson EF; Swenson RE; Greiner J; Gulley J; Eary J; Choyke PL Mol Imaging; 2019; 18():1536012119829986. PubMed ID: 31044647 [TBL] [Abstract][Full Text] [Related]
4. Quantitative PET imaging of PD-L1 expression in xenograft and syngeneic tumour models using a site-specifically labelled PD-L1 antibody. Christensen C; Kristensen LK; Alfsen MZ; Nielsen CH; Kjaer A Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1302-1313. PubMed ID: 31883023 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for Vugts DJ; Klaver C; Sewing C; Poot AJ; Adamzek K; Huegli S; Mari C; Visser GWM; Valverde IE; Gasser G; Mindt TL; van Dongen GAMS Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):286-295. PubMed ID: 27573793 [TBL] [Abstract][Full Text] [Related]
6. Development of a Specifically Labeled Zheng M; Liu Q; Zhang H; Wang Y; Zhang K; Mu H; Fu F; Zhang X; Wang Y; Miao L Mol Pharm; 2024 Oct; 21(10):5205-5216. PubMed ID: 39322604 [TBL] [Abstract][Full Text] [Related]
7. Development of a novel long-lived immunoPET tracer for monitoring lymphoma therapy in a humanized transgenic mouse model. Natarajan A; Habte F; Gambhir SS Bioconjug Chem; 2012 Jun; 23(6):1221-9. PubMed ID: 22621257 [TBL] [Abstract][Full Text] [Related]
8. Advancing Wuensche TE; Stergiou N; Mes I; Verlaan M; Schreurs M; Kooijman EJM; Janssen B; Windhorst AD; Jensen A; Asuni AA; Bang-Andersen B; Beaino W; Dongen GAMS; Vugts DJ Theranostics; 2022; 12(16):7067-7079. PubMed ID: 36276653 [TBL] [Abstract][Full Text] [Related]
9. Imaging diagnosis and efficacy monitoring by [ He H; Qi X; Fu H; Xu J; Zheng Q; Chen L; Zhang Y; Hua H; Xu W; Xu Z; Chen X; You Q; Lin J; Huang G; Mao Y; Yu C Theranostics; 2024; 14(1):392-405. PubMed ID: 38164149 [No Abstract] [Full Text] [Related]
10. Preclinical PET imaging with the novel human antibody Kelly MP; Makonnen S; Hickey C; Arnold TC; Giurleo JT; Tavaré R; Danton M; Granados C; Chatterjee I; Dudgeon D; Retter MW; Ma D; Olson WC; Thurston G; Kirshner JR J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33483343 [TBL] [Abstract][Full Text] [Related]
12. Non-invasive immunoPET imaging of PD-L1 using anti-PD-L1-B11 in breast cancer and melanoma tumor model. Bansal A; Pandey MK; Barham W; Liu X; Harrington SM; Lucien F; Dong H; Park SS; DeGrado TR Nucl Med Biol; 2021; 100-101():4-11. PubMed ID: 34119742 [TBL] [Abstract][Full Text] [Related]
14. Preclinical ImmunoPET Imaging Using a Zr-89-Labeled Anti-CD146 Monoclonal Antibody for Diagnosis of Melanoma. Guo X; Hu M; Zhang Q; Liu J; Shi J; Tang Y; Liu S; Guo J; Kong Y; Zhu H; Yang Z Mol Pharm; 2024 Sep; 21(9):4490-4497. PubMed ID: 39077827 [TBL] [Abstract][Full Text] [Related]
15. Roy J; Jagoda EM; Basuli F; Vasalatiy O; Phelps TE; Wong K; Ton AT; Hagemann UB; Cuthbertson AS; Cole PE; Hassan R; Choyke PL; Lin FI Cancer Biother Radiopharm; 2021 May; 36(4):316-325. PubMed ID: 34014767 [No Abstract] [Full Text] [Related]
16. Jung KH; Park JW; Lee JH; Moon SH; Cho YS; Lee KH J Nucl Med; 2021 May; 62(5):656-664. PubMed ID: 32917780 [TBL] [Abstract][Full Text] [Related]
19. Zirconium- 89 Labeled Antibody K1-70 for PET Imaging of Thyroid-stimulating Hormone Receptor Expression in Thyroid Cancer. Parent EE; Gleba JJ; Knight JA; Kenderian SJ; Copland JA; Cai H Mol Imaging Biol; 2024 Oct; 26(5):847-857. PubMed ID: 39174789 [TBL] [Abstract][Full Text] [Related]
20. Construction and preclinical evaluation of a zirconium-89 labelled monoclonal antibody targeting PD-L2 in lung cancer. Yao Y; Ren Y; Hou X; Zhu J; Ma X; Liu S; Liu T; Zhang Q; Ma X; Yang Z; Zhu H; Li N Biomed Pharmacother; 2023 Dec; 168():115602. PubMed ID: 37852097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]